| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $161 | — | -99.8% |
| Cost of Revenue | $763 | — | -95.8% |
| Gross Profit | -$602 | — | -100.7% |
| R&D Expense | $1.7M | — | -2.0% |
| SG&A Expense | $593K | — | -61.1% |
| Operating Income | -$2.3M | — | +27.8% |
| Pre-tax Income | -$2.5M | — | +25.1% |
| Net Income | -$2.5M | — | +25.1% |
| EPS (Basic) | -$0.41 | — | -95.2% |
| EPS (Diluted) | -$0.41 | — | -95.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.8M | +580.8% | +8.1% |
| Accounts Receivable | $23 | +4.5% | -74.7% |
| Inventory | $316K | +6.8% | +122.5% |
| Current Assets | $3.5M | +209.1% | +15.4% |
| Total Assets | $22.1M | +5.8% | -16.2% |
| Current Liabilities | $6.3M | +488.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$983K | — | +19.7% |
| Capital Expenditures | $9K | — | -74.6% |
| Investing Cash Flow | -$79 | — | +99.6% |
| Financing Cash Flow | $3.4M | — | — |
| Free Cash Flow | -$992K | — | +21.2% |
| +316.6% |
| Total Liabilities | $16.4M | +23.2% | +23.9% |
| Stockholders' Equity | $5.7M | -24.7% | -56.6% |